Master Data Management & Governance Intern

Legend Biotech:
Master Data Management & Governance Intern

Legend Biotech is seeking a Master Data Management & Governance Intern as part of the Technical Operations team based in Raritan, NJ
.

The Master Data Management & Governance Intern will support global data governance activities for cell therapy operations. This role involves ensuring data accuracy, compliance, and integrity across ERP systems and collaborating with global stakeholders.

• Assist in managing master data domains (materials, customers, suppliers).
• Perform data validations and support compliance processes.
• Work with SAP S4 HANA, PAS‑X MES, and BI tools for reporting.
• Document governance activities and follow structured workflows.
• Participate in global projects and cross‑functional meetings.

• Pursuing a Bachelor's or Master's degree in Data Science, Information Systems, Life Sciences, or Engineering.
• Strong analytical and problem‑solving skills.
• Familiarity with ERP systems and data governance concepts.
• Proficiency in Excel; knowledge of SQL or BI tools preferred.
• Desired Academic Grade Level: Junior;
  Senior;
  Graduate Student

• Global exposure to CAR‑T therapy operations.
• Hands‑on experience with master data governance and compliance.
• Technical proficiency with ERP and BI tools.

Important: These benefits are offered exclusively to permanent full‑time employees. Contractors are not eligible for benefits through Legend Biotech.

Legend Biotech is a global biotechnology company dedicated to treating, and one day curing, life‑threatening diseases. Headquartered in Somerset, New Jersey, we are developing advanced cell therapies across a diverse array of technology platforms, including autologous and allogenic chimeric antigen receptor T‑cell, T‑cell receptor (TCR‑T), and natural killer (NK) cell‑based immunotherapy. From our three R&D sites around the world, we apply these innovative technologies to pursue the discovery of safe, efficacious and cutting‑edge therapeutics for patients worldwide.

Legend Biotech entered into a global collaboration agreement with Janssen, one of the pharmaceutical companies of Johnson & Johnson, to jointly develop and commercialize ciltacabtagene autolecuel (cilta‑cel). Our strategic partnership is designed to combine the strengths and expertise of both companies to advance the promise of an immunotherapy in the treatment of multiple myeloma.

It is the policy of Legend Biotech to provide equal employment opportunities without regard to actual or perceived race, color, creed, religion, national origin, ancestry, citizenship status, age, sex or gender (including pregnancy, childbirth, related medical conditions and lactation), gender identity or gender expression (including transgender status), sexual orientation, marital status, military service and veteran status, disability, genetic information, or any other protected characteristic under applicable federal, state or local laws or ordinances.

Employment is at‑will and may be terminated at any time with or without cause or notice by the employee or the company.

For information related to our privacy policy, please review:
Legend Biotech Privacy Policy.